PPP2R3B
Basic information
Region (hg38): Y:333933-386955
Previous symbols: [ "PPP2R3L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP2R3B gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 0 | |||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 0 | 2 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PPP2R3B | protein_coding | protein_coding | ENST00000390665 | 13 | 52993 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.93e-8 | 0.958 | 125551 | 0 | 38 | 125589 | 0.000151 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.40 | 407 | 335 | 1.22 | 0.0000238 | 3695 |
| Missense in Polyphen | 104 | 101.37 | 1.0259 | 1098 | ||
| Synonymous | -4.15 | 228 | 161 | 1.42 | 0.0000141 | 1099 |
| Loss of Function | 1.99 | 16 | 27.2 | 0.588 | 0.00000136 | 300 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000116 | 0.000116 |
| Ashkenazi Jewish | 0.0000998 | 0.0000992 |
| East Asian | 0.000275 | 0.000272 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000143 | 0.000141 |
| Middle Eastern | 0.000275 | 0.000272 |
| South Asian | 0.000230 | 0.000229 |
| Other | 0.000493 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);mRNA surveillance pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Wnt Signaling Pathway and Pluripotency;PI3K-Akt Signaling Pathway;Glycogen Metabolism;Inhibition of replication initiation of damaged DNA by RB1/E2F1;GPCR Dopamine D1like receptor;Cyclin D associated events in G1;G1 Phase;insulin Mam;E2F mediated regulation of DNA replication;Mitotic G1-G1/S phases;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Mitotic G2-G2/M phases;G1/S Transition;Cell Cycle;Cell Cycle, Mitotic;Regulation of retinoblastoma protein;insulin
(Consensus)
Intolerance Scores
- loftool
- 0.691
- rvis_EVS
- 0.34
- rvis_percentile_EVS
- 73.74
Haploinsufficiency Scores
- pHI
- 0.0708
- hipred
- Y
- hipred_score
- 0.519
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein dephosphorylation;cell cycle arrest;regulation of phosphoprotein phosphatase activity
- Cellular component
- protein phosphatase type 2A complex;nucleus;nucleoplasm
- Molecular function
- phosphoprotein phosphatase activity;protein serine/threonine phosphatase activity;calcium ion binding;protein binding;protein phosphatase regulator activity